PHarmaceutical tech@2x
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Next-gen gene editing: Graphite Bio launches with $45m funding
    • Covid-19 pandemic may widen inequality between poor and rich countries – leading macroeconomic influencers
    • Treatment-resistant rare diseases: exploring landmark drug approvals in 2020

    Most Recent

    deal

    Next-gen gene editing: Graphite Bio launches with $45m funding

    30 Sep 2020
  • Investment

    Most Read

    • The relationship between FDI and international trade
    • What is FDI?
    • Why BEPS is a taxing matter for MNCs

    Featured

    TCR2 receives $125m funding boost for T-cell programmes

    22 Mar 2018
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • New Two-Year Data for Evrysdi Will Lead to Increased Competition in SMA Market
    • Bausch Health’s intent to acquire Allegro’s ophthalmology assets offers potential opportunity to tap into lucrative indication-specific markets
    • How digital transformation can bring clinical trials into the 21st century

    Featured

    Regulation

    Janssen gets FDA approval for Invokana to reduce risk of CV events

    31 Oct 2018
  • Deals

    Most Read

    • Next-gen gene editing: Graphite Bio launches with $45m funding
    • Treating lysosomal storage disorders: Gain and Sumitomo Dainippon enter partnership
    • Advancing next-gen CD47 antibodies: AbbVie and I-Mab sign $1.94bn partnership

    Featured

    Clinical Trials

    Blood and urine tests detect autism in children

    21 Feb 2018
  • Tech

    Most Read

    • Five must-read stories from the intersection of tech, business and politics
    • ‘Europe’s Digital Decade’: how the EU is pitching tech as the driving force behind its recovery
    • Five must-read stories from the intersection of tech, business and politics

    Featured

    Cold Chain

    150f drug compounding facilities have violated FDA regulations

    23 Jul 2018
  • Companies

    Sections

    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Alconox
    • Enamine
    • Nymi™

    Featured

    Drug Development

    Cremer

    26 Mar 2020
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
Tools
  • Companies
    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

Allergan divests five dermatology medicines to Almirall for $550m

Allergan has signed a definitive agreement to divest five products under its US Medical Dermatology...

6 August 2018

Latest News

Therapy Areas

SII to produce additional 100 million Covid-19 vaccine doses 

30 Sep 2020
deal

Orgenesis agrees to take over Koligo Therapeutics

30 Sep 2020
Diseases

Pfizer to acquire 9.9% stake in CStone for $200m

30 Sep 2020
deal

XtalPi raises $318m to support AI-based drug discovery

29 Sep 2020

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2020 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.